Evidence map›Paper›PMID 27857711›Full record

ArticleFrontiers in microbiology2016

Aycan Gundogdu, Darajen Bolkvadze, Huseyin Kilic

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Phascinating Phages.Microorganisms · 2022
    Review
  8. Antibiotics (Basel, Switzerland) · 2020
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Aycan GundogduDepartment of Microbiology and Clinical Microbiology, Faculty of Medicine, Erciyes UniversityKayseri, Turkey; Genome and Stem Cell Center (GENKOK), Erciyes UniversityKayseri, Turkey.
Darajen BolkvadzeLaboratory of Molecular Biology, G. Eliava Institute of Bacteriophages, Microbiology and Virology Tbilisi, Georgia.
Huseyin KilicDepartment of Microbiology and Clinical Microbiology, Faculty of Medicine, Erciyes University Kayseri, Turkey.
Erciyes University · TRGeorge Eliava Institute of Bacteriophage, Microbiology and Virology · GE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study is to determine the

Indexed as

antibiotic resistancebacteriophageESBL-E. coliphage therapyphylogenetic grouping

Identifiers

PMID27857711
PMCPMC5093111
OpenAlexW2546493736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.